BR100 Increased By (0.54%)
BR30 Increased By (0.71%)
KSE100 Increased By (0.47%)
KSE30 Increased By (0.46%)
AGHA 6.48 Increased By ▲ 0.03 (0.47%)
BECO 4.14 Decreased By ▼ -0.02 (-0.48%)
BML 58.15 Increased By ▲ 0.84 (1.47%)
BOP 28.34 Increased By ▲ 0.19 (0.67%)
CNERGY 12.54 Increased By ▲ 0.13 (1.05%)
CSIL 5.38 Increased By ▲ 0.02 (0.37%)
FCCL 51.20 Decreased By ▼ -0.46 (-0.89%)
FFL 13.98 Increased By ▲ 0.08 (0.58%)
FNEL 1.09 Increased By ▲ 0.01 (0.93%)
KEL 5.74 Increased By ▲ 0.02 (0.35%)
KOSM 5.36 Increased By ▲ 0.03 (0.56%)
LOTCHEM 24.15 Decreased By ▼ -0.10 (-0.41%)
MLCF 90.07 Increased By ▲ 0.43 (0.48%)
NBP 157.30 Increased By ▲ 0.73 (0.47%)
NCPL 51.72 Increased By ▲ 4.70 (10%)
NPL 57.16 Increased By ▲ 5.20 (10.01%)
OGDC 302.75 Increased By ▲ 2.74 (0.91%)
PACE 9.40 Increased By ▲ 0.14 (1.51%)
PAEL 33.20 Increased By ▲ 0.19 (0.58%)
PIBTL 13.10 Decreased By ▼ -0.09 (-0.68%)
PPL 216.74 Increased By ▲ 2.42 (1.13%)
PRL 100.20 Decreased By ▼ -1.24 (-1.22%)
PTC 52.30 Increased By ▲ 0.06 (0.11%)
SSGC 23.25 Increased By ▲ 0.10 (0.43%)
TBL 8.93 Decreased By ▼ -0.16 (-1.76%)
TELE 6.97 Decreased By ▼ -0.01 (-0.14%)
TPL 22.10 Increased By ▲ 0.06 (0.27%)
TPLP 11.28 Decreased By ▼ -0.41 (-3.51%)
TREET 23.30 Increased By ▲ 0.50 (2.19%)
TRG 57.00 Decreased By ▼ -0.13 (-0.23%)
اردو
Android App
Print Edition Dollar to PKR
Daily Petrol Prices IMF-World Bank meetings Intl Oil Prices Iran-US war Gold Rates Podcasts PSX Notices
World

AstraZeneca to supply COVID-19 antibody cocktail to Singapore

Published Updated
Save
1 min
Comments
By Reuters

SINGAPORE: AstraZeneca said on Friday it will supply Singapore with its COVID-19 antibody cocktail, Evusheld, by the end of the year.

Evusheld can act as another layer of protection, alongside vaccines, for people who are at high risk of COVID-19 infection, according to AstraZeneca's statement.

The company did not specify how many courses of the treatment would be supplied to the Southeast Asian city-state.

The US Food and Drug Administration on Wednesday authorised the use of Evusheld to prevent COVID-19 infections in individuals with weak immune systems or a history of severe side effects from coronavirus vaccines.

AstraZeneca

Comments

Comments are closed for this article.

More Stories

Browse all stories